Skip to main navigation Skip to search Skip to main content

ALK-tyrosine kinase inhibitor intrinsic resistance due to de novo MET-amplification in metastatic ALK-rearranged non-small cell lung cancer effectively treated by alectinib-crizotinib combination-case report

Edyta M Urbanska, Morten Grauslund, Siv M S Berger, Junia C Costa, Peter R Koffeldt, Jens B Sørensen, Eric Santoni-Rugiu*

*Corresponding author for this work
3 Citations (Scopus)

Fingerprint

Dive into the research topics of 'ALK-tyrosine kinase inhibitor intrinsic resistance due to de novo MET-amplification in metastatic ALK-rearranged non-small cell lung cancer effectively treated by alectinib-crizotinib combination-case report'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology